Buket AKSU, Özgen ÖZER, Sakine TUNCAY TANRIVERDİ, Gülşen YILMAZ, Gizem YEĞEN

Preparation and in vitro characterization of etofenamate emulgels using quality by design

Quality by Design (QbD) emerged with quality guidelines issued by the International Council on Harmonization (ICH); is a concept that suggests the quality of product cannot be secured by the finish product tests; product quality should be ensured by starting from risk and scientific based work in process and product development through the whole product life cycle. Statistical studies, which are done by computer program, have important role in today’s pharmaceutical area. ANN (Artificial Neural Network) and GEP (Gene Expression Programming) are modelling techniques can be used for analyzing big amount of data, in understanding the relations between dependent and independent variables affecting product quality and optimizing the formulation variables and process parameters to get the desired product quality continuously. In this study, different etofenamate emulgel formulations were prepared, the quality characteristics determined to be critical were evaluated separately with the ANN, and GEP modeling techniques for the optimization of the formulations examined. During the modeling, the input values were oil type, oil ratio and polymer ratio and the outputs were pH, conductivity, viscosity and flow properties of the emulgels. According to results of pre-formulation studies both of the programs suggested two optimized formulations. Depending on the further studies, the viscosity and rheological behavior showed that both formulations were could apply on skin.

PDF

___

International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Pharmaceutical Development Guideline Q8 2009. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Gui deline.pdf (accessed June 18, 2019).
Pallagi E, Ambrusb R, Szabo-Reveszb P, Csoka I. Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation. Int J Pharm. 2015; 491: 384-392. [CrossRef]
Demir Ö, Aksu B, Özsoy Y. Araştırma geliştirme çalışmalarında tasarımla kalite yaklaşımı ve yapay sinir ağı modellemesinin önemi. Türkiye Klinikleri J Pharm Sci. 2015; 4(1): 17-35. [CrossRef]
Okyar A, Özsoy Y, Güngör S. Novel formulation approaches for dermal and transdermal delivery of non-steroidal anti-inflammatory drugs. In: Lemmey A. (Ed). Rheumatoid arthritis–treatment. Intech, Croatia, 2012, pp. 25-48. [CrossRef]
Pena LE. Gel dosage forms: theory, formulation and processing. In: Osborne DW, Amann AH. (Eds). Topical drug delivery formulations. Marcel Dekker, New York, 1990, pp. 381-388.
Steven P, Stanos DO. Topical agents for the management of musculoskeletal pain. J Pain Symptom Manag. 2007; 33(3): 342-355. [CrossRef]
Sunil KY, Manoj KM, Anumapaa T, Ashutosh S. Emulgel a new approach for enhanced for topical drug delivery. Int J Curr Pharm Res. 2017; 9(1): 15-19. [CrossRef]
Hardenia A, Jayronia S, Jain S. Emulgel: an emergent tool in topical drug delivery. Int J Pharm Sci Rev Res. 2014; 5(5): 1653-1660. [CrossRef]
Jana S, Ali SA, Nayak AK, Sen KK, Basu SK. Development of topical gel containing aceclofenac-crospovidone solid dispersion by “quality by design (QbD)” approach. Chem Eng Res Des. 2014; 9(2): 2095-2105. [CrossRef]
Mohamed MI. Optimization of chlorphenesin emulgel formulation. AAPS J. 2004; 6(3): 81–87. [CrossRef]
Jones DS, Woolfson AD, Brown AF. Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm. 1997; 151(2): 223-233. [CrossRef]
Andrews GP, Gorman SP, Jones DS. Rheological characterization of primary and binary interactive bioadhesive gels composed of cellulose derivatives designed as ophthalmic viscosurgical devices. Biomaterials. 2015; 26(5): 571–580. [CrossRef]
Aksu B, Gokce EH, Rencber S, Ozyazıcı M. Optimization of solid lipid nanoparticles using Gene Expression Programming (GEP). Lat Am J Pharm. 2014; 33(4): 675-84.
Aksu B, Yegen G. Benefits of computerized technologies in pharmaceutical development with quality by design approach. J Comput Eng Inf Technol. 2017; 6(1):1-6. [CrossRef]